AR and hepatocellular carcinoma: While existing evidence indicates that SF and AR, or their individual active constituents, can influence inflammation-related pathways in HCC, the precise downstream pathways affected by the combined SF-AR formulation and its specific role in regulating tumor growth remain to be fully elucidated.